FARALLON CAPITAL MANAGEMENT LLC - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 188 filers reported holding ASCENDIS PHARMA A/S in Q1 2024. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q1 2024$16,477,530
-66.6%
109,000
-70.9%
0.08%
-62.7%
Q2 2021$49,331,000
-61.7%
375,000
-62.5%
0.20%
-68.6%
Q1 2021$128,880,000
-22.7%
1,000,0000.0%0.64%
-36.2%
Q4 2020$166,780,000
-13.5%
1,000,000
-20.0%
1.00%
-24.8%
Q3 2020$192,900,000
+14.4%
1,250,000
+9.6%
1.33%
-1.1%
Q2 2020$168,606,000
+8.8%
1,140,000
-17.2%
1.35%
+1.4%
Q1 2020$154,991,000
-12.9%
1,376,349
+7.6%
1.33%
+10.7%
Q4 2019$177,934,000
+19.2%
1,279,000
-17.5%
1.20%
+6.5%
Q3 2019$149,296,000
-15.8%
1,550,000
+0.6%
1.13%
-2.2%
Q2 2019$177,331,000
+0.4%
1,540,000
+2.7%
1.15%
-13.2%
Q1 2019$176,550,000
+88.0%
1,500,000
+0.0%
1.33%
+92.7%
Q4 2018$93,931,000
-9.0%
1,499,297
+2.9%
0.69%
+13.0%
Q3 2018$103,264,000
+6.5%
1,457,2970.0%0.61%
+1.8%
Q2 2018$96,939,000
+15.2%
1,457,297
+13.2%
0.60%
+2.7%
Q1 2018$84,157,0001,286,8000.58%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q1 2024
NameSharesValueWeighting ↓
RA Capital Management 4,240,536$300,484,00016.06%
Sofinnova Investments, Inc. 2,479,514$175,698,00015.66%
Vivo Capital, LLC 2,166,832$153,542,00015.48%
VHCP Management II, LLC 504,210$35,728,0009.54%
EcoR1 Capital, LLC 1,087,257$77,043,0006.94%
Avoro Capital Advisors LLC 1,963,336$139,122,0006.39%
Foresite Capital Management IV, LLC 245,424$17,391,0005.70%
Eventide Asset Management 1,544,900$109,472,0004.02%
Orbimed Advisors 4,155,891$294,486,0003.55%
Ghost Tree Capital, LLC 225,000$15,944,0003.39%
View complete list of ASCENDIS PHARMA A/S shareholders